(244 days)
No
The device description and performance studies focus on mechanical components and clinical outcomes related to the physical abutment system, with no mention of AI/ML or related concepts like image processing, training data, or performance metrics typically associated with AI/ML algorithms.
No.
The Rodo Abutment System is intended to provide support for crowns, bridges, or overdentures in conjunction with compatible implant systems, making it a prosthetic support device rather than a therapeutic device that treats or prevents a disease.
No
The Rodo Abutment System is described as providing support for crowns, bridges, or overdentures in conjunction with compatible implant systems, and allows for the attachment and removal of prosthetic restorations. Its purpose is to physically support and connect dental prostheses, not to diagnose medical conditions or diseases.
No
The device description explicitly lists multiple physical components (Rodo Abutment, Smileloc Sleeve, Silicone Seal, Titanium Coping, Temporary Cap, abutment screws, and Smileloc Activator/Remover). These are hardware components, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information for diagnosis, monitoring, or screening.
- Rodo Abutment System Function: The Rodo Abutment System is a dental implant component used in vivo (within the body) to support dental prosthetics (crowns, bridges, overdentures). It is a mechanical device used for structural support and attachment, not for analyzing biological samples.
The description clearly outlines its use in the mouth to connect dental implants to restorations, which is a completely different function from an IVD.
N/A
Intended Use / Indications for Use
Rodo Abutment System is intended to be used in conjunction with compatible implant systems in the maxillary or mandibular arch to provide support for crowns, bridges or overdentures.
Compatible Systems:
- Straumann Bone Level
- OEM Platform Size: NC, RC
- OEM Body Size: 3.3, 4.1, 4.8
- Neodent Drive CM
- OEM Platform Size: 3.5, 4.3, 5.0
- OEM Body Size: 3.5, 4.3, 5.0
- Neodent Titamax CM
- OEM Platform Size: 3.5, 3.75, 4.0, 5.0
- OEM Body Size: 3.5, 3.75, 4.0, 5.0
- Neodent Alvim CM
- OEM Platform Size: 3.5, 4.3, 5.0
- OEM Body Size: 3.5, 4.3, 5.0
- NobelActive
- OEM Platform Size: 3.0, NP, RP, WP
- OEM Body Size: 3.0, 3.5, 4.3, 5.0, 5.5
- Nobel Replace Conical
- OEM Platform Size: NP, RP
- OEM Body Size: 3.5, 4.3, 5.0
- NobelReplace Straight
- OEM Platform Size: NP, RP, WP
- OEM Body Size: 3.5, 4.0, 5.0
- NobelReplace Tapered
- OEM Platform Size: NP, RP, WP, 6.0
- OEM Body Size: 3.5, 4.3, 5.0, 6.0
- NobelSpeedy Replace
- OEM Platform Size: NP, RP, WP, 6.0
- OEM Body Size: 3.5, 4.0, 5.0, 6.0
Product codes (comma separated list FDA assigned to the subject device)
NHA
Device Description
The Rodo Abutment System includes the Rodo Abutment, Smileloc Sleeve, Silicone Seal, Titanium Coping, Temporary Cap, abutment screws, and Smileloc Activator (or Smileloc Remover). The Smileloc Sleeve is used to lock and unlock the Titanium Coping for final restoration to or from the abutment. This makes the prosthesis removable.
Rodo Abutment is provided in five series designs (100 F. 200 P. 300 S. 400 M. 500 D) with the 200 P and 500 D series having angled abutments (17°, 30°), for a total of nine designs. The 200 P and 500 D series are designed for multi-unit restorations only, the 300 S series is designed for limited occlusal space, and the 400 M series is designed for large interproximal spaces. Abutments are available in sizes ranging from ⌀ 3.0 mm depending on the compatible implant system in use. Designs are available with engaging and non-engaging implant-abutment interfaces.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
maxillary or mandibular arch
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical testing data submitted or relied upon to demonstrate substantial equivalence included: steam sterilization validation according to ISO 17665-1 and ISO 17665-2, demonstrating a sterility assurance level (SAL) of 10-6; biocompatibility testing according to ISO 10993-5 (cytotoxicity) and ISO 10993-10 (sensitization and irritation). demonstrating acceptable biocompatibility; electrical safety analysis according to AAMI / ANSI ES60601-1:2005/(R) 2012 and A1:2012, c1:2009/(R) 2012 and a2:2010/(r) 2012, IEC 60601-1-2 and IEC 62366 and risk analysis according to ISO 14971, demonstrating acceptable electrical safety; thermal properties testing according to ASTM F2004, showing acceptable transition temperatures; corrosion testing according to ASTM G71 and ASTM F2129 and nickel leaching evaluation, showing acceptable corrosion resistance; retention testing, showing acceptable retention strength; reverse engineering and dimensional analysis of OEM devices, showing that the Rodo Abutment is compatible with corresponding OEM implants; and dynamic compression-bending testing according to ISO 14801, showing mechanical performance sufficient for its intended use.
A prospective multi-center clinical trial, designed to evaluate the safety and effectiveness of the Rodo Abutment System for dental implants, was conducted under an Investigational Device Exemption study according to FDA guidelines. The Rodo Abutment System was used with corresponding compatible implant systems. A total of thirty-four (34) subjects (17 male, 17 female), with previously implants ready for restoration, were enrolled at two study centers. Thirty-two subjects received Rodo Abutments and restorations. Three of these subjects each received four Rodo abutments as part of their full arch, immediate load treatment. In total, 41 Rodo Abutments were placed and restored.
Of the nine adverse events recorded over the duration of the study, two were abutment screw loosening (resolved by re-tightening the screw), one was separation of the crown from the coping due to inadequate bonding in the laboratory (resolved by re-bonding in the laboratory), and the remaining six events were not device related. No adverse events were related to the Smileloc sleeve or attachment of the prosthesis to the abutment.
The overall conclusion from the study was that the Rodo Abutment System provides an appropriate method of attaching prosthetic restorations to dental implant abutments. If necessary, it allows repeated removal of the restoration, as is the case for screw-retained restorations on dental implant abutments.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K062129, K101945, K123022, K142260, K073142, K050705, K050406, K142118
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of three human profiles facing right, arranged in a stacked, overlapping manner. The profiles are rendered in a dark color, creating a sense of depth and unity. The logo is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
November 21, 2016
Rodo Medical, Inc. c/o Ms. Linda Schulz Regulatory Affairs PaxMed International, LLC 12264 El Camino Real Suite 400 San Diego, California 92130
Re: K160786
Trade/Device Name: Rodo Abutment System Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: October 21, 2016 Received: October 24, 2016
Dear Ms. Linda Schulz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Michael J. Ryan -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
510(k) Number (if known)
K160786
Device Name
Rodo Abutment System
Indications for Use (Describe)
Rodo Abutment System is intended to be used in conjunction with compatible implant systems in the maxillary or mandibular arch to provide support for crowns, bridges or overdentures.
| Implant Line | OEM Platform Size | OEM Body Size |
|---|---|---|
| Straumann Bone Level | NC, RC | 3.3, 4.1, 4.8 |
| Neodent Drive CM | 3.5, 4.3, 5.0 | 3.5, 4.3, 5.0 |
| Neodent Titamax CM | 3.5, 3.75, 4.0, 5.0 | 3.5, 3.75, 4.0, 5.0 |
| Neodent Alvim CM | 3.5, 4.3, 5.0 | 3.5, 4.3, 5.0 |
| NobelActive | 3.0, NP, RP, WP | 3.0, 3.5, 4.3, 5.0, 5.5 |
| Nobel Replace Conical | NP, RP | 3.5, 4.3, 5.0 |
| NobelReplace Straight | NP, RP, WP | 3.5, 4.0, 5.0 |
| NobelReplace Tapered | NP, RP, WP, 6.0 | 3.5, 4.3, 5.0, 6.0 |
| NobelSpeedy Replace | NP, RP, WP, 6.0 | 3.5, 4.0, 5.0, 6.0 |
Compatible Systems
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary Rodo Medical, Inc. Rodo Abutment System K160786
November 21, 2016
ADMINISTRATIVE INFORMATION
| Manufacturer Name | Rodo Medical, Inc. |
|---|---|
| 690 Saratoga Ave., Suite 100 | |
| San Jose, CA 95129 | |
| Telephone: +1 (408) 245-7636 | |
| Fax: +1 (408) 338-6940 | |
| Official Contact | Michael Parsons |
| Executive Vice President | |
| Representative/Consultant | Linda K. Schulz, BSDH, RDH |
| Kevin A. Thomas, PhD | |
| PaxMed International, LLC | |
| 12264 El Camino Real, Suite 400 | |
| San Diego, CA 92130 | |
| Telephone: +1 (858) 792-1235 | |
| Fax: +1 (858) 792-1236 | |
| Email: lschulz@paxmed.com | |
| kthomas@paxmed.com |
DEVICE NAME AND CLASSIFICATION
| Trade/Proprietary Name | Rodo Abutment System |
|---|---|
| Common Name | Endosseous dental implant abutment |
| Classification Name | Endosseous dental implant abutment |
| Classification Regulations | 21 CFR 872.3630, Class II |
| Product Code | NHA |
| Classification Panel | Dental Products Panel |
| Reviewing Branch | Dental Devices Branch |
PREDICATE DEVICE INFORMATION
Primary Predicate K120414, OsseoSpeed™ Plus, Astra Tech AB
Reference Predicates Abutment Design K092341, Low Profile Abutment, Biomet 3i
Compatibility
K062129, P.004 Implants, Institut Straumann AG K101945, Neodent Implant System, JJGC Indústria e Comércio de Materiais Dentários SA K 123022, Neodent Implant System, JJGC Indústria e Comércio de Materiais Dentários SA K142260, NobelActive®, Nobel Biocare AB
4
K073142, NobelReplace Hexagonal Implants, Nobel Biocare AB K050705, TiUnite® Implants, Nobel Biocare USA LLC K050406, NOBELSPEEDY® Implants, Nobel Biocare AB K142118. Inclusive® Titanium Abutments compatible with: Straumann Bone Level, Nobel Biocare Branemark, and Nobel Biocare NobelActive Implants, Prismatik Dentalcraft, Inc.
INDICATIONS FOR USE
Rodo Abutment System is intended to be used in conjunction with compatible implant systems in the maxillary or mandibular arch to provide support for crowns, bridges or overdentures.
| Implant Line | OEM Platform Size | OEM Body Size |
|---|---|---|
| Straumann Bone Level | NC, RC | 3.3, 4.1, 4.8 |
| Neodent Drive CM | 3.5, 4.3, 5.0 | 3.5, 4.3, 5.0 |
| Neodent Titamax CM | 3.5, 3.75, 4.0, 5.0 | 3.5, 3.75, 4.0, 5.0 |
| Neodent Alvim CM | 3.5, 4.3, 5.0 | 3.5, 4.3, 5.0 |
| NobelActive | 3.0, NP, RP, WP | 3.0, 3.5, 4.3, 5.0, 5.5 |
| Nobel Replace Conical | NP, RP | 3.5, 4.3, 5.0 |
| NobelReplace Straight | NP, RP, WP | 3.5, 4.0, 5.0 |
| NobelReplace Tapered | NP, RP, WP, 6.0 | 3.5, 4.3, 5.0, 6.0 |
| NobelSpeedy Replace | NP, RP, WP, 6.0 | 3.5, 4.0, 5.0, 6.0 |
Compatible Systems
DEVICE DESCRIPTION
The Rodo Abutment System includes the Rodo Abutment, Smileloc Sleeve, Silicone Seal, Titanium Coping, Temporary Cap, abutment screws, and Smileloc Activator (or Smileloc Remover). The Smileloc Sleeve is used to lock and unlock the Titanium Coping for final restoration to or from the abutment. This makes the prosthesis removable.
Rodo Abutment is provided in five series designs (100 F. 200 P. 300 S. 400 M. 500 D) with the 200 P and 500 D series having angled abutments (17°, 30°), for a total of nine designs. The 200 P and 500 D series are designed for multi-unit restorations only, the 300 S series is designed for limited occlusal space, and the 400 M series is designed for large interproximal spaces. Abutments are available in sizes ranging from 0 3.0 mm depending on the compatible implant system in use. Designs are available with engaging and non-engaging implant-abutment interfaces.
PERFORMANCE DATA
Non-clinical testing data submitted or relied upon to demonstrate substantial equivalence included: steam sterilization validation according to ISO 17665-1 and ISO 17665-2, demonstrating a sterility assurance level (SAL) of 10°; biocompatibility testing according to ISO 10993-5 (cytotoxicity) and ISO 10993-10 (sensitization and irritation). demonstrating acceptable biocompatibility; electrical safety analysis according to AAMI / ANSI ES60601-1:2005/(R) 2012 and A1:2012, c1:2009/(R) 2012 and a2:2010/(r) 2012, IEC 60601-1-2 and IEC 62366 and risk analysis according to ISO 14971, demonstrating acceptable electrical safety; thermal properties testing according to ASTM F2004, showing acceptable transition temperatures; corrosion testing according to ASTM G71 and ASTM F2129 and nickel leaching evaluation, showing acceptable corrosion resistance; retention testing, showing acceptable retention strength; reverse engineering and dimensional analysis of OEM devices, showing that the Rodo Abutnent is compatible with corresponding OEM implants; and dynamic compression-bending testing according to ISO 14801, showing mechanical performance sufficient for its intended use.
5
CLINICAL DATA
A prospective multi-center clinical trial, designed to evaluate the safety and effectiveness of the Rodo Abutment System for dental implants, was conducted under an Investigational Device Exemption study according to FDA guidelines. The Rodo Abutment System was used with corresponding compatible implant systems. A total of thirtyfour (34) subjects (17 male, 17 female), with previously implants ready for restoration, were enrolled at two study centers. Thirty-two subjects received Rodo Abutments and restorations. Three of these subjects each received four Rodo abutments as part of their full arch, immediate load treatment. In total, 41 Rodo Abutments were placed and restored.
Of the nine adverse events recorded over the duration of the study, two were abutment screw loosening (resolved by re-tightening the screw), one was separation of the crown from the coping due to inadequate bonding in the laboratory (resolved by re-bonding in the laboratory), and the remaining six events were not device related. No adverse events were related to the Smileloc sleeve or attachment of the prosthesis to the abutment.
The overall conclusion from the study was that the Rodo Abutment System provides an appropriate method of attaching prosthetic restorations to dental implant abutments. If necessary, it allows repeated removal of the restoration, as is the case for screw-retained restorations on dental implant abutments.
EQUIVALENCE TO MARKETED DEVICE
The subject device is substantially equivalent in indications and design principles to the predicate devices shown above.
Rodo Abutment System is substantially equivalent to the OsseoSpeed Plus implant system (K120414) and Low Profile Abutment (K092341). Rodo Abutment System has two coping designs for Smileloc-retained (Smileloc Sleeve) prostheses while OsseoSpeed Plus (K1204140 has three different coping types for the fabrication of screwretained prostheses (prosthetic screw). Both prosthetic coping systems are for single or multi-unit restorations that are removable. Rodo Abutment System and Low Profile Abutment (K092341) are available with 17° and 30° angled abutments.
Rodo Abutment System abutments range in size from Ø 3.0 mm. OsseoSpeed Plus Abutments range in size from Ø 3.0 mm to Ø 5.4 mm. Low Profile Abutments range in size from Ø 3.0 mm.
The Indications for Use for the Rodo Abutment System are substantially equivalent to those of OsseoSpeed Plus and Low Profile Abutment. Minor differences in Indications for Use language between the systems do not change the intended use of support for prostheses in the maxillary or mandibular arch.
Below is a summary table comparing the Indications for Use and the technological characteristics of the subject device and the predicate devices.
6
510(k) Summary
Page 4 of 5
Table of Substantial Equivalence
| Subject Device | Primary Predicate | Reference Predicate | Reference Predicate | |
|---|---|---|---|---|
| Rodo Medical, Inc. | ||||
| Rodo Abutment System | Astra Tech AB | |||
| OsseoSpeed™ Plus | Biomet 3i | |||
| Low Profile Abutment | Prismatik Dentalcraft, Inc., | |||
| Inclusive® Titanium | ||||
| Abutments compatible with: | ||||
| Straumann Bone Level, Nobel | ||||
| Biocare Branemark, and Nobel | ||||
| Biocare NobelActive Implants | ||||
| K160786 | K120414 | K092341 | K142118 | |
| Indications | ||||
| for Use | Rodo Abutment System is intended to be used in conjunction | |||
| with compatible implant systems in the maxillary or | ||||
| mandibular arch to provide support for crowns, bridges or | ||||
| overdentures. | Implants: | |||
| The Astra Tech Dental Implants are intended for both | ||||
| one- and two-stage surgical procedures in the | ||||
| following situations and with the following clinical | ||||
| protocols: | BIOMET 3i Low Profile | |||
| Abutments are intended for | ||||
| use as accessories to | ||||
| endosseous dental implants | ||||
| to support a prosthetic | ||||
| device in a partially or | ||||
| completely edentulous | ||||
| patient. A dental abutment is | ||||
| intended for use to support | ||||
| single and multiple tooth | ||||
| prosthesis, in the mandible | ||||
| or maxilla. The prosthesis is | ||||
| screw retained to the | ||||
| abutment. | Inclusive® Titanium Abutments | |||
| are premanufactured prosthetic | ||||
| components directly connected to | ||||
| endosseous dental implants and | ||||
| are intended for use as an aid in | ||||
| prosthetic rehabilitation. | ||||
| Inclusive® Titanium Abutments | ||||
| are compatible with: |
- Straumann: Bone Level NC and
RC implant sizes - Nobel Biocare: Branemark RP
size implant - Nobel Biocare NobelActive NP
and RP internal connection
implants |
| | Compatible Systems | · replacing single and multiple missing teeth in the
mandible and maxilla,
· immediate placement in extraction sites and in
situations with a partially or completely healed
alveolar ridge,
· especially indicated for use in soft bone applications
where implants with other implant surface treatments
may be less effective,
· immediate loading in all indications, except in
single tooth situations on implants shorter than 8 mm
or in soft bone (type IV) where implant stability may
be difficult to obtain and immediate loading may not
be appropriate. | | |
| | Implant Line | | | |
| | OEM Platform
Size | | | |
| | OEM Body Size | | | |
| | Straumann Bone Level | NC, RC | 3.3, 4.1, 4.8 | |
| | Neodent Drive CM | 3.5, 4.3, 5.0 | 3.5, 4.3, 5.0 | |
| | Neodent Titamax CM | 3.5, 3.75, 4.0, 5.0 | 3.5, 3.75, 4.0, 5.0 | |
| | Neodent Alvim CM | 3.5, 4.3, 5.0 | 3.5, 4.3, 5.0 | |
| | NobelActive | 3.0, NP, RP, WP | 3.0, 3.5, 4.3, 5.0, 5.5 | |
| | Nobel Replace Conical | NP, RP | 3.5, 4.3, 5.0 | |
| | NobelReplace Straight | NP, RP, WP | 3.5, 4.0, 5.0 | |
| | NobelReplace Tapered | NP, RP, WP, 6.0 | 3.5, 4.3, 5.0, 6.0 | |
| | NobelSpeedy Replace | NP, RP, WP, 6.0 | 3.5, 4.0, 5.0, 6.0 | |
| | | The intended use for OsseoSpeed™ Plus 3.0S is
limited to replacement of maxillary lateral incisors
and mandibular incisors.
Abutments:
Astra Tech Implant System Plus abutments are
intended to be used in conjunction with Astra Tech
Implant System Plus in fully edentulous or partially
edentulous maxillary and/or mandibular arches to
provide support for crowns, bridges or overdentures. | | |
| Design | | | | |
| Prosthesis
Attachment | Smileloc Sleeve (Nitinol alloy) | Screw-retained, Cement-retained | Screw Retained | Screw-retained |
| Restoration | Single-unit, Multi-units | Single-unit, Multi-unit | Single-unit, Multi-unit | Single-unit, Multi-unit |
| Abutment
Platform
Diameters | 3.0 mm - 6.0 mm | 3.0 mm - 5.4 mm | 3.4 mm - 5.0 mm | 3.3 - 4.8 mm |
| Abutment
Material | Titanium alloy | Titanium alloy | Titanium alloy | Titanium alloy |
7
CONCLUSION
The subject device and the predicate devices have intended use, have similar technological characteristics, and are made of similar materials. The subject devices encompass the same range of physical dimensions, including diameter, gingival height, and angle of the abutments. The subject and predicate devices are packaged in similar materials and are to be sterilized using similar methods.
The data included in this submission demonstrate substantial equivalence to the predicate devices listed above.